Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-49

[2] Ferlay J(2020)Colorectal cancer statistics, 2020 CA Cancer J Clin 70 145-64

[3] Siegel RL(2016)A review of Neoadjuvant Chemoradiotherapy for locally advanced rectal Cancer Int J Biol Sci 12 1022-31

[4] Laversanne M(2021)The Evolving Field of Neoadjuvant Therapy in locally-advanced rectal Cancer: evidence and prospects Clin Colorectal Cancer 20 288-98

[5] Soerjomataram I(2016)Neoadjuvant treatment strategies for locally advanced rectal Cancer Clin Oncol (R Coll Radiol (G B)) 28 146-51

[6] Jemal A(2017)PSMB8 as a candidate marker of responsiveness to Preoperative Radiation Therapy in rectal Cancer patients Int J Radiat Oncol Biol Phys 98 1164-73

[7] Bray F(2015)A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients Cancer Biol Ther 16 1160-71

[8] Siegel RL(2017)Gene and MicroRNA expression are Predictive of Tumor response in rectal adenocarcinoma patients treated with preoperative chemoradiotherapy J Cell Physiol 232 426-35

[9] Miller KD(2021)The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancer Lancet Oncol 22 e314-26

[10] Goding Sauer A(2018)Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial Ann Oncol 29 1521-7

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-49

[2] Ferlay J(2020)Colorectal cancer statistics, 2020 CA Cancer J Clin 70 145-64

[3] Siegel RL(2016)A review of Neoadjuvant Chemoradiotherapy for locally advanced rectal Cancer Int J Biol Sci 12 1022-31

[4] Laversanne M(2021)The Evolving Field of Neoadjuvant Therapy in locally-advanced rectal Cancer: evidence and prospects Clin Colorectal Cancer 20 288-98

[5] Soerjomataram I(2016)Neoadjuvant treatment strategies for locally advanced rectal Cancer Clin Oncol (R Coll Radiol (G B)) 28 146-51

[6] Jemal A(2017)PSMB8 as a candidate marker of responsiveness to Preoperative Radiation Therapy in rectal Cancer patients Int J Radiat Oncol Biol Phys 98 1164-73

[7] Bray F(2015)A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients Cancer Biol Ther 16 1160-71

[8] Siegel RL(2017)Gene and MicroRNA expression are Predictive of Tumor response in rectal adenocarcinoma patients treated with preoperative chemoradiotherapy J Cell Physiol 232 426-35

[9] Miller KD(2021)The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancer Lancet Oncol 22 e314-26

[10] Goding Sauer A(2018)Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial Ann Oncol 29 1521-7